{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,21]],"date-time":"2026-11-21T15:48:56Z","timestamp":1795276136394,"version":"4.10.3"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Neurosci"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Controversies over anti-amyloid immunotherapies underscore the need to elucidate their mechanisms of action. Here we demonstrate that Lecanemab, a leading anti-\u03b2-amyloid (A\u03b2) antibody, mediates amyloid clearance by activating microglial effector functions. Using a human microglia xenograft mouse model, we show that Lecanemab significantly reduces A\u03b2 pathology and associated neuritic damage, while neither fragment crystallizable (Fc)-silenced Lecanemab nor microglia deficiency elicits this effect despite intact plaque binding. Single-cell RNA sequencing and spatial transcriptomic analyses reveal that Lecanemab induces a focused transcriptional program that enhances phagocytosis, lysosomal degradation, metabolic reprogramming, interferon\n                    <jats:italic>\u03b3<\/jats:italic>\n                    genes and antigen presentation. Finally, we identify\n                    <jats:italic>SPP1<\/jats:italic>\n                    \/osteopontin as a major factor induced by Lecanemab treatment and demonstrate its role in promoting A\u03b2 clearance. These findings highlight that effective amyloid removal depends on the engagement of microglia through the Fc fragment, providing critical insights for optimizing anti-amyloid therapies in Alzheimer\u2019s disease.\n                  <\/jats:p>","DOI":"10.1038\/s41593-025-02125-8","type":"journal-article","created":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T10:02:58Z","timestamp":1763978578000},"page":"100-110","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["The Alzheimer\u2019s therapeutic Lecanemab attenuates A\u03b2 pathology by inducing an amyloid-clearing program in microglia"],"prefix":"10.1038","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8215-2432","authenticated-orcid":false,"given":"Giulia","family":"Albertini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9641-9778","authenticated-orcid":false,"given":"Magdalena","family":"Zielonka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7540-389X","authenticated-orcid":false,"given":"Marie-Lynn","family":"Cuypers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An","family":"Snellinx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8280-1736","authenticated-orcid":false,"given":"Ciana","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suresh","family":"Poovathingal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2711-1264","authenticated-orcid":false,"given":"Marta","family":"Wojno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2182-1249","authenticated-orcid":false,"given":"Kristofer","family":"Davie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4033-4286","authenticated-orcid":false,"given":"Veerle","family":"van Lieshout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katleen","family":"Craessaerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leen","family":"Wolfs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Pasciuto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7485-4397","authenticated-orcid":false,"given":"Tom","family":"Jaspers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrien","family":"Horr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lurgarde","family":"Serneels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Fiers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3138-281X","authenticated-orcid":false,"given":"Maarten","family":"Dewilde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5455-5819","authenticated-orcid":false,"given":"Bart","family":"De Strooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,24]]},"reference":[{"key":"2125_CR1","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.nbd.2009.08.007","volume":"36","author":"A Lord","year":"2009","unstructured":"Lord, A. et al. An amyloid-\u03b2 protofibril-selective antibody prevents amyloid formation in a mouse model of Alzheimer\u2019s disease. Neurobiol. Dis. 36, 425\u2013434 (2009).","journal-title":"Neurobiol. Dis."},{"key":"2125_CR2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH Van Dyck","year":"2022","unstructured":"Van Dyck, C. H. et al. Lecanemab in early Alzheimer\u2019s disease. N. Engl. J. Med. 388, 9\u201321 (2022).","journal-title":"N. Engl. J. Med."},{"key":"2125_CR3","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/s41573-022-00391-w","volume":"21","author":"E Karran","year":"2022","unstructured":"Karran, E. & de Strooper, B. The amyloid hypothesis in Alzheimer disease: new insights from new therapeutics. Nat. Rev. Drug Discov. 21, 306\u2013318 (2022).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2125_CR4","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.neuron.2012.10.029","volume":"76","author":"RB DeMattos","year":"2012","unstructured":"DeMattos, R. B. et al. A plaque-specific antibody clears existing \u03b2-amyloid plaques in Alzheimer\u2019s disease mice. Neuron 76, 908\u2013920 (2012).","journal-title":"Neuron"},{"key":"2125_CR5","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature19323","volume":"537","author":"J Sevigny","year":"2016","unstructured":"Sevigny, J. et al. The antibody aducanumab reduces A\u03b2 plaques in Alzheimer\u2019s disease. Nature 537, 50\u201356 (2016).","journal-title":"Nature"},{"key":"2125_CR6","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20231363","volume":"221","author":"MP Cadiz","year":"2024","unstructured":"Cadiz, M. P. et al. Aducanumab anti-amyloid immunotherapy induces sustained microglial and immune alterations. J. Exp. Med. 221, e20231363 (2024).","journal-title":"J. Exp. Med."},{"key":"2125_CR7","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1160\/TH12-10-0768","volume":"109","author":"F Carbone","year":"2013","unstructured":"Carbone, F., Nencioni, A., Mach, F., Vuilleumier, N. & Montecucco, F. Evidence on the pathogenic role of auto-antibodies in acute cardiovascular diseases. Thromb. Haemost. 109, 854\u2013868 (2013).","journal-title":"Thromb. Haemost."},{"key":"2125_CR8","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1038\/s41591-022-01926-9","volume":"28","author":"H Jung","year":"2022","unstructured":"Jung, H. et al. Anti-inflammatory clearance of amyloid-\u03b2 by a chimeric Gas6 fusion protein. Nat. Med. 28, 1802\u20131812 (2022).","journal-title":"Nat. Med."},{"key":"2125_CR9","volume":"8","author":"X-Y Sun","year":"2023","unstructured":"Sun, X.-Y. et al. Fc effector of anti-A\u03b2 antibody induces synapse loss and cognitive deficits in Alzheimer\u2019s disease-like mouse model. Signal Transduct. Target. Ther. 8, 30 (2023).","journal-title":"Signal Transduct. Target. Ther."},{"key":"2125_CR10","doi-asserted-by":"crossref","first-page":"7873","DOI":"10.1523\/JNEUROSCI.22-18-07873.2002","volume":"22","author":"BJ Bacskai","year":"2002","unstructured":"Bacskai, B. J. et al. Non-Fc-mediated mechanisms are involved in clearance of amyloid-\u03b2 in vivo by immunotherapy. J. Neurosci. 22, 7873\u20137878 (2002).","journal-title":"J. Neurosci."},{"key":"2125_CR11","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.nbd.2007.07.019","volume":"28","author":"M Garcia-Alloza","year":"2007","unstructured":"Garcia-Alloza, M. et al. A limited role for microglia in antibody mediated plaque clearance in APP mice. Neurobiol. Dis. 28, 286\u2013292 (2007).","journal-title":"Neurobiol. Dis."},{"key":"2125_CR12","doi-asserted-by":"crossref","first-page":"8532","DOI":"10.1523\/JNEUROSCI.23-24-08532.2003","volume":"23","author":"P Das","year":"2003","unstructured":"Das, P. et al. Amyloid-\u03b2 immunization effectively reduces amyloid deposition in FcR\u03b3 \u2212\/\u2212 knock-out mice. J. Neurosci. 23, 8532\u20138538 (2003).","journal-title":"J. Neurosci."},{"key":"2125_CR13","volume":"21","author":"E Fertan","year":"2025","unstructured":"Fertan, E. et al. Lecanemab preferentially binds to smaller aggregates present at early Alzheimer\u2019s disease. Alzheimers Dement. 21, e70086 (2025).","journal-title":"Alzheimers Dement."},{"key":"2125_CR14","doi-asserted-by":"crossref","first-page":"3900","DOI":"10.1074\/jbc.M116.767749","volume":"292","author":"M Lo","year":"2017","unstructured":"Lo, M. et al. Effector-attenuating substitutions that maintain antibody stability and reduce toxicity in mice. J. Biol. Chem. 292, 3900\u20133908 (2017).","journal-title":"J. Biol. Chem."},{"key":"2125_CR15","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/protein\/gzw040","volume":"29","author":"T Schlothauer","year":"2016","unstructured":"Schlothauer, T. et al. Novel human IgG1 and IgG4 Fc-engineered antibodies with completely abolished immune effector functions. Protein Eng. Des. Sel. 29, 457\u2013466 (2016).","journal-title":"Protein Eng. Des. Sel."},{"key":"2125_CR16","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1038\/s41593-024-01600-y","volume":"27","author":"R Mancuso","year":"2024","unstructured":"Mancuso, R. et al. Xenografted human microglia display diverse transcriptomic states in response to Alzheimer\u2019s disease-related amyloid-\u03b2 pathology. Nat. Neurosci. 27, 886\u2013900 (2024).","journal-title":"Nat. Neurosci."},{"key":"2125_CR17","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-54779-w","volume":"15","author":"N Balig\u00e1cs","year":"2024","unstructured":"Balig\u00e1cs, N. et al. Homeostatic microglia initially seed and activated microglia later reshape amyloid plaques in Alzheimer\u2019s disease. Nat. Commun. 15, 10634 (2024).","journal-title":"Nat. Commun."},{"key":"2125_CR18","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-11053-8","volume":"10","author":"R Rojo","year":"2019","unstructured":"Rojo, R. et al. Deletion of a Csf1r enhancer selectively impacts CSF1R expression and development of tissue macrophage populations. Nat. Commun. 10, 3215 (2019).","journal-title":"Nat. Commun."},{"key":"2125_CR19","doi-asserted-by":"crossref","first-page":"575","DOI":"10.3233\/JAD-140741","volume":"43","author":"S Tucker","year":"2014","unstructured":"Tucker, S. et al. The murine version of BAN2401 (mAb158) selectively reduces amyloid-\u03b2 protofibrils in brain and cerebrospinal fluid of tg-ArcSwe mice. J. Alzheimers Dis. 43, 575\u2013588 (2014).","journal-title":"J. Alzheimers Dis."},{"key":"2125_CR20","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.cell.2020.06.038","volume":"182","author":"W-T Chen","year":"2020","unstructured":"Chen, W.-T. et al. Spatial transcriptomics and in situ sequencing to study Alzheimer\u2019s disease. Cell 182, 976\u2013991 (2020).","journal-title":"Cell"},{"key":"2125_CR21","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114216","volume":"43","author":"A Mallach","year":"2024","unstructured":"Mallach, A. et al. Microglia-astrocyte crosstalk in the amyloid plaque niche of an Alzheimer\u2019s disease mouse model, as revealed by spatial transcriptomics. Cell Rep. 43, 114216 (2024).","journal-title":"Cell Rep."},{"key":"2125_CR22","volume":"4","author":"S Poovathingal","year":"2024","unstructured":"Poovathingal, S. et al. Nova-ST: nano-patterned ultra-dense platform for spatial transcriptomics. Cell Rep. Methods 4, 100831 (2024).","journal-title":"Cell Rep. Methods"},{"key":"2125_CR23","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.neuron.2017.02.001","volume":"93","author":"I Espuny-Camacho","year":"2017","unstructured":"Espuny-Camacho, I. et al. Hallmarks of Alzheimer\u2019s disease in stem-cell-derived human neurons transplanted into mouse brain. Neuron 93, 1066\u20131081 (2017).","journal-title":"Neuron"},{"key":"2125_CR24","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nn.3697","volume":"17","author":"T Saito","year":"2014","unstructured":"Saito, T. et al. Single App knock-in mouse models of Alzheimer\u2019s disease. Nat. Neurosci. 17, 661\u2013663 (2014).","journal-title":"Nat. Neurosci."},{"key":"2125_CR25","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-23111-1","volume":"12","author":"A Grubman","year":"2021","unstructured":"Grubman, A. et al. Transcriptional signature in microglia associated with A\u03b2 plaque phagocytosis. Nat. Commun. 12, 3015 (2021).","journal-title":"Nat. Commun."},{"key":"2125_CR26","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.cell.2024.01.012","volume":"187","author":"AR Lawrence","year":"2024","unstructured":"Lawrence, A. R. et al. Microglia maintain structural integrity during fetal brain morphogenesis. Cell 187, 962\u2013980 (2024).","journal-title":"Cell"},{"key":"2125_CR27","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.neuron.2018.12.006","volume":"101","author":"Q Li","year":"2019","unstructured":"Li, Q. et al. Developmental heterogeneity of microglia and brain myeloid cells revealed by deep single-cell RNA sequencing. Neuron 101, 207\u2013223 (2019).","journal-title":"Neuron"},{"key":"2125_CR28","volume":"41","author":"S Li","year":"2022","unstructured":"Li, S. & Jakobs, T. C. Secreted phosphoprotein 1 slows neurodegeneration and rescues visual function in mouse models of aging and glaucoma. Cell Rep. 41, 111880 (2022).","journal-title":"Cell Rep."},{"key":"2125_CR29","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aau2291","volume":"11","author":"Y Deming","year":"2019","unstructured":"Deming, Y. et al. The MS4A gene cluster is a key modulator of soluble TREM2 and Alzheimer\u2019s disease risk. Sci. Transl. Med. 11, eaau2291 (2019).","journal-title":"Sci. Transl. Med."},{"key":"2125_CR30","first-page":"11","volume":"10","author":"N Soejima","year":"2013","unstructured":"Soejima, N. et al. Intracellular accumulation of toxic turn amyloid-\u03b2 is associated with endoplasmic reticulum stress in Alzheimer\u2019s disease. Curr. Alzheimer Res. 10, 11\u201320 (2013).","journal-title":"Curr. Alzheimer Res."},{"key":"2125_CR31","volume":"13","author":"AE Murphy","year":"2022","unstructured":"Murphy, A. E. & Skene, N. G. A balanced measure shows superior performance of pseudobulk methods in single-cell RNA-sequencing analysis. Nat. Commun. 13, 7851 (2022).","journal-title":"Nat. Commun."},{"key":"2125_CR32","volume":"12","author":"A Jana","year":"2022","unstructured":"Jana, A. et al. Increased type I interferon signaling and brain endothelial barrier dysfunction in an experimental model of Alzheimer\u2019s disease. Sci. Rep. 12, 16488 (2022).","journal-title":"Sci. Rep."},{"key":"2125_CR33","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.101880","volume":"298","author":"Y Tachida","year":"2022","unstructured":"Tachida, Y. et al. Endothelial expression of human amyloid precursor protein leads to amyloid \u03b2 in the blood and induces cerebral amyloid angiopathy in knock-in mice. J. Biol. Chem. 298, 101880 (2022).","journal-title":"J. Biol. Chem."},{"key":"2125_CR34","doi-asserted-by":"crossref","DOI":"10.1186\/s13024-023-00660-1","volume":"18","author":"K Uekawa","year":"2023","unstructured":"Uekawa, K. et al. Border-associated macrophages promote cerebral amyloid angiopathy and cognitive impairment through vascular oxidative stress. Mol. Neurodegener. 18, 73 (2023).","journal-title":"Mol. Neurodegener."},{"key":"2125_CR35","volume":"15","author":"X Huang","year":"2024","unstructured":"Huang, X. et al. Clearance and transport of amyloid \u03b2 by peripheral monocytes correlate with Alzheimer\u2019s disease progression. Nat. Commun. 15, 7998 (2024).","journal-title":"Nat. Commun."},{"key":"2125_CR36","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-08352-5","volume":"10","author":"N Rosenzweig","year":"2019","unstructured":"Rosenzweig, N. et al. PD-1\/PD-L1 checkpoint blockade harnesses monocyte-derived macrophages to combat cognitive impairment in a tauopathy mouse model. Nat. Commun. 10, 465 (2019).","journal-title":"Nat. Commun."},{"key":"2125_CR37","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1304365","volume":"14","author":"T Damelang","year":"2024","unstructured":"Damelang, T. et al. Impact of structural modifications of IgG antibodies on effector functions. Front. Immunol. 14, 1304365 (2024).","journal-title":"Front. Immunol."},{"key":"2125_CR38","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s13311-022-01308-6","volume":"20","author":"L S\u00f6derberg","year":"2023","unstructured":"S\u00f6derberg, L. et al. Lecanemab, aducanumab, and gantenerumab\u2014binding profiles to different forms of amyloid-\u03b2 might explain efficacy and side effects in clinical trials for Alzheimer\u2019s disease. Neurotherapeutics 20, 195\u2013206 (2023).","journal-title":"Neurotherapeutics"},{"key":"2125_CR39","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1471-4159.2007.04759.x","volume":"103","author":"H Englund","year":"2007","unstructured":"Englund, H. et al. Sensitive ELISA detection of amyloid-\u03b2 protofibrils in biological samples. J. Neurochem. 103, 334\u2013345 (2007).","journal-title":"J. Neurochem."},{"key":"2125_CR40","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/s41596-020-00447-4","volume":"16","author":"N Fattorelli","year":"2021","unstructured":"Fattorelli, N. et al. Stem-cell-derived human microglia transplanted into mouse brain to study human disease. Nat. Protoc. 16, 1013\u20131033 (2021).","journal-title":"Nat. Protoc."},{"key":"2125_CR41","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1038\/s41593-019-0525-x","volume":"22","author":"R Mancuso","year":"2019","unstructured":"Mancuso, R. et al. Stem-cell-derived human microglia transplanted in mouse brain to study human disease. Nat. Neurosci. 22, 2111\u20132116 (2019).","journal-title":"Nat. Neurosci."},{"key":"2125_CR42","doi-asserted-by":"crossref","DOI":"10.1186\/s13024-020-00399-z","volume":"15","author":"L Serneels","year":"2020","unstructured":"Serneels, L. et al. Modeling the \u03b2-secretase cleavage site and humanizing amyloid-\u03b2 precursor protein in rat and mouse to study Alzheimer\u2019s disease. Mol. Neurodegener. 15, 60 (2020).","journal-title":"Mol. Neurodegener."},{"key":"2125_CR43","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.celrep.2019.03.099","volume":"27","author":"C Sala Frigerio","year":"2019","unstructured":"Sala Frigerio, C. et al. The major risk factors for Alzheimer\u2019s disease: age, sex, and genes modulate the microglia response to A\u03b2 plaques. Cell Rep. 27, 1293\u20131306 (2019).","journal-title":"Cell Rep."},{"key":"2125_CR44","doi-asserted-by":"publisher","unstructured":"Poovathingal, S., Davie, K. & Aerts, S. Nova-ST spatial transcriptomics protocol v1. protocols.io https:\/\/doi.org\/10.17504\/protocols.io.3byl4925jgo5\/v1 (2024).","DOI":"10.17504\/protocols.io.3byl4925jgo5\/v1"},{"key":"2125_CR45","doi-asserted-by":"publisher","unstructured":"Poovathingal, S., Davie, K. & Aerts, S. Nova-ST chip preparation protocol v1. protocols.io https:\/\/doi.org\/10.17504\/protocols.io.n92ld835ov5b\/v1 (2024).","DOI":"10.17504\/protocols.io.n92ld835ov5b\/v1"},{"key":"2125_CR46","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/s41596-024-01065-0","volume":"20","author":"Y Kim","year":"2025","unstructured":"Kim, Y. et al. Seq-scope: repurposing Illumina sequencing flow cells for high-resolution spatial transcriptomics. Nat. Protoc. 20, 643\u2013689 (2025).","journal-title":"Nat. Protoc."},{"key":"2125_CR47","volume":"19","author":"FA Wolf","year":"2018","unstructured":"Wolf, F. A., Angerer, P. & Theis, F. J. SCANPY: large-scale single-cell gene expression data analysis. Genome Biol. 19, 15 (2018).","journal-title":"Genome Biol."},{"key":"2125_CR48","unstructured":"Franklin, K. B. J. & Paxinos, G. Paxinos and Franklin\u2019s the Mouse Brain in Stereotaxic Coordinates, Compact: The Coronal Plates and Diagrams, Fifth Edition (Academic Press, 2019)."},{"key":"2125_CR49","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.neuron.2017.03.042","volume":"94","author":"EM Abud","year":"2017","unstructured":"Abud, E. M. et al. iPSC-derived human microglia-like cells to study neurological diseases. Neuron 94, 278\u2013293 (2017).","journal-title":"Neuron"},{"key":"2125_CR50","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/s41593-022-01022-8","volume":"25","author":"SE Marsh","year":"2022","unstructured":"Marsh, S. E. et al. Dissection of artifactual and confounding glial signatures by single-cell sequencing of mouse and human brain. Nat. Neurosci. 25, 306\u2013316 (2022).","journal-title":"Nat. Neurosci."},{"key":"2125_CR51","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573\u20133587 (2021).","journal-title":"Cell"},{"key":"2125_CR52","doi-asserted-by":"crossref","DOI":"10.1186\/s13059-018-1603-1","volume":"19","author":"M Stoeckius","year":"2018","unstructured":"Stoeckius, M. et al. Cell Hashing with barcoded antibodies enables multiplexing and doublet detection for single cell genomics. Genome Biol. 19, 224 (2018).","journal-title":"Genome Biol."},{"key":"2125_CR53","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.cels.2019.03.003","volume":"8","author":"CS McGinnis","year":"2019","unstructured":"McGinnis, C. S., Murrow, L. M. & Gartner, Z. J. DoubletFinder: doublet detection in single-cell RNA sequencing data using artificial nearest neighbors. Cell Syst. 8, 329\u2013337 (2019).","journal-title":"Cell Syst."},{"key":"2125_CR54","doi-asserted-by":"crossref","DOI":"10.1186\/s13059-019-1874-1","volume":"20","author":"C Hafemeister","year":"2019","unstructured":"Hafemeister, C. & Satija, R. Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression. Genome Biol. 20, 296 (2019).","journal-title":"Genome Biol."},{"key":"2125_CR55","doi-asserted-by":"crossref","DOI":"10.21105\/joss.00861","volume":"3","author":"L McInnes","year":"2018","unstructured":"McInnes, L., Healy, J., Saul, N. & Gro\u00dfberger, L. UMAP: uniform manifold approximation and projection. J. Open Source Softw. 3, 861 (2018).","journal-title":"J. Open Source Softw."},{"key":"2125_CR56","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2125_CR57","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu, T. et al. clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innovation (Camb) 2, 100141 (2021).","journal-title":"Innovation (Camb)"},{"key":"2125_CR58","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaq0305","volume":"10","author":"CY Fonseka","year":"2018","unstructured":"Fonseka, C. Y. et al. Mixed-effects association of single cells identifies an expanded effector CD4 + T cell subset in rheumatoid arthritis. Sci. Transl. Med. 10, eaaq0305 (2018).","journal-title":"Sci. Transl. Med."},{"key":"2125_CR59","volume":"3","author":"S Morabito","year":"2023","unstructured":"Morabito, S., Reese, F., Rahimzadeh, N., Miyoshi, E. & Swarup, V. hdWGCNA identifies co-expression networks in high-dimensional transcriptomics data. Cell Rep. Methods 3, 100498 (2023).","journal-title":"Cell Rep. Methods"},{"key":"2125_CR60","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/75556","volume":"25","author":"M Ashburner","year":"2000","unstructured":"Ashburner, M. et al. Gene ontology: tool for the unification of biology. Nat. Genet. 25, 25\u201329 (2000).","journal-title":"Nat. Genet."},{"key":"2125_CR61","doi-asserted-by":"crossref","DOI":"10.1093\/genetics\/iyad031","volume":"224","author":"Gene Ontology Consortium","year":"2023","unstructured":"Gene Ontology Consortium et al. The gene ontology knowledgebase in 2023. Genetics 224, iyad031 (2023).","journal-title":"Genetics"},{"key":"2125_CR62","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0289619","volume":"18","author":"K Hristova","year":"2023","unstructured":"Hristova, K. & Wimley, W. C. Determining the statistical significance of the difference between arbitrary curves: a spreadsheet method. PLoS ONE 18, e0289619 (2023).","journal-title":"PLoS ONE"},{"key":"2125_CR63","doi-asserted-by":"publisher","unstructured":"Zielonka, M. & Albertini, G. Analysis code for: The Alzheimer's therapeutic Lecanemab attenuates A\u03b2 pathology by inducing an amyloid-clearing program in microglia (v1.0.0). Zenodo https:\/\/doi.org\/10.5281\/zenodo.17098382 (2025).","DOI":"10.5281\/zenodo.17098382"}],"container-title":["Nature Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41593-025-02125-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41593-025-02125-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41593-025-02125-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T14:33:06Z","timestamp":1767796386000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41593-025-02125-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,24]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["2125"],"URL":"https:\/\/doi.org\/10.1038\/s41593-025-02125-8","relation":{},"ISSN":["1097-6256","1546-1726"],"issn-type":[{"value":"1097-6256","type":"print"},{"value":"1546-1726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,24]]},"assertion":[{"value":"30 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"B.D.S. has been a consultant for Eli Lilly, Biogen, Janssen Pharmaceutica, Eisai, AbbVie and other companies and is now a consultant to Muna Therapeutics. B.D.S. is also a scientific founder of Augustine Therapeutics and a scientific founder and stockholder of Muna Therapeutics. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}